These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 28093207)
1. p53 mediates the suppression of cancer cell invasion by inducing LIMA1/EPLIN. Ohashi T; Idogawa M; Sasaki Y; Tokino T Cancer Lett; 2017 Apr; 390():58-66. PubMed ID: 28093207 [TBL] [Abstract][Full Text] [Related]
2. AKR1B10, a transcriptional target of p53, is downregulated in colorectal cancers associated with poor prognosis. Ohashi T; Idogawa M; Sasaki Y; Suzuki H; Tokino T Mol Cancer Res; 2013 Dec; 11(12):1554-63. PubMed ID: 24140838 [TBL] [Abstract][Full Text] [Related]
3. Epithelial Protein Lost in Neoplasm, EPLIN, the Cellular and Molecular Prospects in Cancers. Zeng J; Jiang WG; Sanders AJ Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356662 [TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of the intercellular adhesion molecule-2 gene as a novel p53 target. Sasaki Y; Tamura M; Takeda K; Ogi K; Nakagaki T; Koyama R; Idogawa M; Hiratsuka H; Tokino T Oncotarget; 2016 Sep; 7(38):61426-61437. PubMed ID: 27556181 [TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA NEAT1 is a transcriptional target of p53 and modulates p53-induced transactivation and tumor-suppressor function. Idogawa M; Ohashi T; Sasaki Y; Nakase H; Tokino T Int J Cancer; 2017 Jun; 140(12):2785-2791. PubMed ID: 28295289 [TBL] [Abstract][Full Text] [Related]
6. DNp73 exerts function in metastasis initiation by disconnecting the inhibitory role of EPLIN on IGF1R-AKT/STAT3 signaling. Steder M; Alla V; Meier C; Spitschak A; Pahnke J; Fürst K; Kowtharapu BS; Engelmann D; Petigk J; Egberts F; Schäd-Trcka SG; Gross G; Nettelbeck DM; Niemetz A; Pützer BM Cancer Cell; 2013 Oct; 24(4):512-27. PubMed ID: 24135282 [TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of a metastatic suppressor BRMS1L as a target gene of p53. Koyama R; Tamura M; Nakagaki T; Ohashi T; Idogawa M; Suzuki H; Tokino T; Sasaki Y Cancer Sci; 2017 Dec; 108(12):2413-2421. PubMed ID: 29030916 [TBL] [Abstract][Full Text] [Related]
8. Characterization of LIMA1 and its emerging roles and potential therapeutic prospects in cancers. Wang X; Zhang C; Song H; Yuan J; Zhang X; Yuan Y; Zhang L; He J Front Oncol; 2023; 13():1115943. PubMed ID: 37274282 [TBL] [Abstract][Full Text] [Related]
9. TRIAD1 Is a Novel Transcriptional Target of p53 and Regulates Nutlin-3a-Induced Cell Death. Lee J; An S; Choi YM; Jung JH; Li L; Meng H; Dong Y; Ahn KJ; An IS; Bae S J Cell Biochem; 2017 Jul; 118(7):1733-1740. PubMed ID: 27935098 [TBL] [Abstract][Full Text] [Related]
10. The therapeutic potential of p53 reactivation by nutlin-3a in ALK+ anaplastic large cell lymphoma with wild-type or mutated p53. Drakos E; Atsaves V; Schlette E; Li J; Papanastasi I; Rassidakis GZ; Medeiros LJ Leukemia; 2009 Dec; 23(12):2290-9. PubMed ID: 19741726 [TBL] [Abstract][Full Text] [Related]
11. Homozygous mdm2 SNP309 cancer cells with compromised transcriptional elongation at p53 target genes are sensitive to induction of p53-independent cell death. Rosso M; Polotskaia A; Bargonetti J Oncotarget; 2015 Oct; 6(33):34573-91. PubMed ID: 26416444 [TBL] [Abstract][Full Text] [Related]
12. PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21. Hu F; Gartenhaus RB; Eichberg D; Liu Z; Fang HB; Rapoport AP Oncogene; 2010 Oct; 29(40):5464-74. PubMed ID: 20622899 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of p53-murine double minute 2 interaction by nutlin-3A stabilizes p53 and induces cell cycle arrest and apoptosis in Hodgkin lymphoma. Drakos E; Thomaides A; Medeiros LJ; Li J; Leventaki V; Konopleva M; Andreeff M; Rassidakis GZ Clin Cancer Res; 2007 Jun; 13(11):3380-7. PubMed ID: 17545546 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the antitumor effects of an MDM2 inhibitor, nutlin-3, in feline lymphoma cell lines with or without p53 mutation. Mochizuki H; Goto-Koshino Y; Sato M; Fujino Y; Ohno K; Tsujimoto H Vet Immunol Immunopathol; 2012 Jun; 147(3-4):187-94. PubMed ID: 22578852 [TBL] [Abstract][Full Text] [Related]
15. Wild-type p53 inhibits pro-invasive properties of TGF-β3 in breast cancer, in part through regulation of EPHB2, a new TGF-β target gene. Lam S; Wiercinska E; Teunisse AF; Lodder K; ten Dijke P; Jochemsen AG Breast Cancer Res Treat; 2014 Nov; 148(1):7-18. PubMed ID: 25257729 [TBL] [Abstract][Full Text] [Related]